Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles.
about
Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study.Diabetes mellitus, but not small dense low-density lipoprotein, is predictive of cardiovascular disease: A Korean community-based prospective cohort study.Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia?Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapyCombination drug treatment in obese diabetic patientsDyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: the case for residual risk reduction after statin treatmentFish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring.A review of time courses and predictors of lipid changes with fenofibric acid-statin combination.The role of psychobiological and neuroendocrine mechanisms in appetite regulation and obesity.Persistence of an atherogenic lipid profile after treatment of acute infection with Brucella.Review article: effects of plant sterols and stanols beyond low-density lipoprotein cholesterol lowering.Emerging options in the treatment of dyslipidemias: a bright future?Combinations of ezetimibe with nonstatin drug regimens affecting lipid metabolism.Fenofibrate plus simvastatin (fixed-dose combination) for the treatment of dyslipidaemia.Effects of rosuvastatin versus atorvastatin on small dense low-density lipoprotein: a meta-analysis of randomized trials.Emerging drugs for hyperlipidaemia: an update.Ezetimibe alone or in combination with simvastatin increases small dense low-density lipoproteins in healthy men: a randomized trial.Pharmacological management of diabetic dyslipidemia.Update on the role of the atherogenic lipoprotein phenotype in cardiovascular prevention.Ezetimibe, cardiovascular risk and atherogenic dyslipidaemia.Usefulness of the LDL-C/apoB ratio in the overall evaluation of atherogenicity of lipid profile.Combination drug treatment in patients with non-alcoholic fatty liver disease.Effects of rosiglitazone on fasting and postprandial low- and high-density lipoproteins size and subclasses in type 2 diabetes.Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study.Efficacy and safety of ezetimibe plus orlistat or rimonabant in statin-intolerant nondiabetic overweight/obese patients with dyslipidemia.
P2860
Q21262011-7603B739-D5E5-49B5-A759-FC1BD1748987Q33607720-4C6A80C7-0302-4E47-95A0-770A18F4EB60Q33776187-304F963C-2EBA-4E5A-8527-A61FF37D40BDQ34417470-095B1C1D-34F5-4261-9E3A-945149BB6A39Q34877652-DD3951DC-CD5E-4516-99BC-9D8B23F756FDQ35029623-051423D4-01DB-4E67-B6CE-EFAFB151D733Q35541900-3838CEAF-95B3-470D-9DD8-689F1BF12CC1Q36011053-F8324097-0FA7-4DEB-9C33-839764B2063CQ36547159-620B3A38-A5A9-491E-A645-1ED4145C7633Q37430645-C88D31FB-236B-4D17-B308-50D3E367D53CQ37702056-332076EA-C61A-495E-B45D-2364EFDC9EA0Q37842462-D9D588C5-BC92-4DA9-B1B6-6BB7F0D872F2Q37857866-027586F3-70C1-47C0-9026-C0798D7160A1Q37898699-A9EF57F6-A088-4556-B87E-713F673F9EFDQ38104228-E45B917B-AACB-4C21-B7F7-FD114EE7AA70Q38263909-EC49235B-9B8F-47AC-AF41-E85170F2AEBBQ38372936-E547ADDB-F82C-42A4-9980-58EFBE1FBB88Q39015072-EEC82741-8F9B-4841-AEA0-C83DA6A559EDQ40179094-282BBFF1-8EC7-4058-8918-D3248FA86FD5Q40413933-448BBAF0-D908-4567-88C3-9B1139513342Q40680512-7F9F5CEB-4F6A-49AB-BC86-FC158D1D2AE7Q41128646-6946F82C-BA14-429D-A374-CA2987C2A2ADQ42169796-228D67AC-72F9-46F2-AA8F-26EDA8E0A37DQ42284569-409B96BC-1D95-4550-8B2D-E3543805A964Q43282311-28DC5B33-BC3C-4042-B285-5C6FE9B0F463
P2860
Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Clinical importance and therap ...... density lipoprotein particles.
@ast
Clinical importance and therap ...... density lipoprotein particles.
@en
type
label
Clinical importance and therap ...... density lipoprotein particles.
@ast
Clinical importance and therap ...... density lipoprotein particles.
@en
prefLabel
Clinical importance and therap ...... density lipoprotein particles.
@ast
Clinical importance and therap ...... density lipoprotein particles.
@en
P2093
P2860
P356
P1476
Clinical importance and therap ...... density lipoprotein particles.
@en
P2093
Alexandros D Tselepis
Irene F Gazi
Moses Elisaf
Vasilis Tsimihodimos
P2860
P356
10.1517/14712598.7.1.53
P407
P577
2007-01-01T00:00:00Z